管制非法兴奋剂：一个有规管的市场模式。
Controlling illegal stimulants: a regulated market model.
机构信息
Vancouver Coastal Health Authority, Pacific Spirit Community Health Centre, 2110 West 43rd Ave, Vancouver, British Columbia, V6K 2E1, Canada.
出版信息
Harm Reduct J. 2008 Jan 23;5:1. doi: 10.1186/1477-7517-5-1.
Abstract
Prohibition of illegal drugs is a failed social policy and new models of regulation of these substances are needed. This paper explores a proposal for a post-prohibition, public health based model for the regulation of the most problematic drugs, the smokable and injectable stimulants. The literature on stimulant maintenance is explored. Seven foundational principles are suggested that could support this regulatory model of drug control that would reduce both health and social problems related to illegal stimulants. Some details of this model are examined and the paper concludes that drug policies need to be subject to research and based on evidence.
摘要
禁止非法药物是一项失败的社会政策，需要新的监管模式来规范这些物质。本文探讨了一种针对最具问题性药物（可吸食和可注射的兴奋剂）的后禁止、基于公共卫生的监管模式的提案。本文探讨了兴奋剂维持治疗的文献。提出了七条基本原则，这些原则可以支持这种管制毒品的监管模式，从而减少与非法兴奋剂有关的健康和社会问题。本文还研究了该模式的一些细节，并得出结论认为，药物政策需要接受研究并基于证据。
相似文献
1
Controlling illegal stimulants: a regulated market model.管制非法兴奋剂：一个有规管的市场模式。
Harm Reduct J. 2008 Jan 23;5:1. doi: 10.1186/1477-7517-5-1.
2
Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory.运用间断平衡理论理解新西兰对新型精神活性物质进行管制性市场管理的发展。
Addiction. 2018 Nov;113(11):2132-2139. doi: 10.1111/add.14260. Epub 2018 Jun 8.
3
Prohibition, regulation or laissez faire: The policy trade-offs of cannabis policy.禁止、管制还是放任自流：大麻政策的政策权衡。
Int J Drug Policy. 2018 Jun;56:153-161. doi: 10.1016/j.drugpo.2018.03.024. Epub 2018 Apr 7.
4
Decriminalisation and smart regulation of psychoactive substances: a modern alternative to prohibition.精神活性物质的非刑罪化与明智监管：一种替代禁令的现代方式。
Cas Lek Cesk. 2023;162(6):231-237.
5
What are the policy lessons of National Alcohol Prohibition in the United States, 1920-1933?美国 1920-1933 年的全国禁酒令有哪些政策教训？
Addiction. 2010 Jul;105(7):1164-73. doi: 10.1111/j.1360-0443.2010.02926.x. Epub 2010 Mar 10.
6
A Public-Health-Based Vision for the Management and Regulation of Psychedelics.基于公共卫生的迷幻剂管理与监管愿景。
J Psychoactive Drugs. 2016 Sep-Oct;48(4):243-52. doi: 10.1080/02791072.2016.1202459. Epub 2016 Jul 18.
7
Sources of nonmedically used prescription stimulants: differences in onset, recency and severity of misuse in a population-based study.非医疗用途处方兴奋剂的来源：一项基于人群的研究中滥用的起始时间、近期情况及严重程度差异
Drug Alcohol Depend. 2014 Dec 1;145:106-12. doi: 10.1016/j.drugalcdep.2014.09.781. Epub 2014 Oct 12.
8
Public health, not social warfare: a public health approach to illegal drug policy.公共卫生，而非社会战争：非法毒品政策的公共卫生方法
J Public Health Policy. 1991 Autumn;12(3):278-323.
9
Heroin and the illegal drug overdose death epidemic: A history of missed opportunities and resistance.海洛因与非法药物过量死亡 epidemic：错失机会与抵制的历史。
Int J Drug Policy. 2021 May;91:102938. doi: 10.1016/j.drugpo.2020.102938. Epub 2020 Nov 25.
10
New psychoactive substances: Are there any good options for regulating new psychoactive substances?新型精神活性物质：对于管控新型精神活性物质，是否存在任何可行的办法？
Int J Drug Policy. 2017 Feb;40:117-122. doi: 10.1016/j.drugpo.2016.10.020. Epub 2016 Nov 23.
引用本文的文献
1
Reprint of: The regulation project: Tools for engaging the public in the legal regulation of drugs.重印：《监管项目：让公众参与药品法律监管的工具》
Int J Drug Policy. 2021 May;91:103279. doi: 10.1016/j.drugpo.2021.103279.
2
The regulation project: Tools for engaging the public in the legal regulation of drugs.监管项目：让公众参与药品法律监管的工具。
Int J Drug Policy. 2020 Oct 10;86:102949. doi: 10.1016/j.drugpo.2020.102949.
本文引用的文献
1
The globalization of ayahuasca: harm reduction or benefit maximization?死藤水的全球化：减少危害还是利益最大化？
Int J Drug Policy. 2008 Aug;19(4):297-303. doi: 10.1016/j.drugpo.2006.11.001. Epub 2006 Dec 4.
2
Canada's 2003 renewed drug strategy--an evidence-based review.加拿大2003年更新的药物战略——基于证据的审查。
HIV AIDS Policy Law Rev. 2006 Dec;11(2-3):1, 5-12.
3
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.使用大麻可改善丙型肝炎患者治疗后的病毒学指标及病毒载量控制情况。
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1057-63. doi: 10.1097/01.meg.0000216934.22114.51.
4
Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and questions.非法药物使用者患者中丙型肝炎病毒治疗与大麻使用：影响与问题
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1039-42. doi: 10.1097/01.meg.0000236869.93527.b9.
5
Attendance at supervised injecting facilities and use of detoxification services.在受监督注射设施的出勤情况及戒毒服务的使用情况。
N Engl J Med. 2006 Jun 8;354(23):2512-4. doi: 10.1056/NEJMc052939.
6
Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis.瑞士苏黎世海洛因使用的发病率：一项治疗病例登记分析。
Lancet. 2006 Jun 3;367(9525):1830-4. doi: 10.1016/S0140-6736(06)68804-1.
7
Policy makers ignoring science and scientists ignoring policy: the medical ethical challenges of heroin treatment.政策制定者忽视科学，科学家忽视政策：海洛因治疗的医学伦理挑战。
Harm Reduct J. 2006 May 2;3:16. doi: 10.1186/1477-7517-3-16.
8
Antiquity of coca-leaf chewing in the south central Andes: a 3,000 year archaeological record of coca-leaf chewing from northern Chile.安第斯中南部嚼食古柯叶的悠久历史：来自智利北部的3000年古柯叶嚼食考古记录
J Psychoactive Drugs. 2005 Dec;37(4):455-8. doi: 10.1080/02791072.2005.10399820.
9
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.美国大都市地区吸毒者中威慑与执法对毒品相关危害的影响
AIDS. 2006 Jan 2;20(1):93-9. doi: 10.1097/01.aids.0000196176.65551.a3.
10
Drug replacement treatments: is amphetamine substitution a horse of a different colour?药物替代疗法：苯丙胺替代疗法是否另当别论？
Drug Alcohol Rev. 1995;14(4):389-94. doi: 10.1080/09595239500185531.
Zotero 插件